CLINICAL_TRIALS
trial_result
· 2021-06-28
Clinical Trial Update: A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations [Phase 4]
Summary
A Phase 4 clinical trial evaluating skin irritation potential of 11 topically applied formulations in healthy volunteers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Molnlycke Health Care AB | Conditions: Skin Irritancy Potential | Phase 4 | Status: UNKNOWN